Pd-1 Inhibitor: Clinical Trials

1 trial of Pd-1 Inhibitor, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Not yet recruiting 1

Follow Pd-1 Inhibitor: new trials by email Literature Review of Pd-1 Inhibitor trials Research Report on Pd-1 Inhibitor

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Prospective Trial of SFI Plus PD-1 Inhibitors and PBC in Resectable NSCLC (SFI-NSCLC)
Shenqi Fuzheng Injection - Tear Disorder, Resectable Locally Advanced Non-Squamous NSCLC
Phase 4Not yet recruitingAnhui Provincial Cancer Hospital302026-10-152026-10-29

Sponsors

Anhui Provincial Cancer Hospital (1)

Top investigators

Pan Yue Yin, Doctoral degree (1)

Results publications

PMID 17762336, PMID 20969765, PMID 37921708, PMID 41784638